These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 6548688

  • 21. Drug review and postmarketing surveillance programs are sound, but systems approach to risk management is needed, says FDA.
    Miller JL.
    Am J Health Syst Pharm; 1999 Jul 01; 56(13):1294,6. PubMed ID: 10683122
    [No Abstract] [Full Text] [Related]

  • 22. Assessing Drug Safety in Children - The Role of Real-World Data.
    McMahon AW, Dal Pan G.
    N Engl J Med; 2018 Jun 07; 378(23):2155-2157. PubMed ID: 29874532
    [No Abstract] [Full Text] [Related]

  • 23. FDA turns to electronic "sentinel" to flag prescription drug safety problems.
    Kuehn BM.
    JAMA; 2008 Jul 09; 300(2):156-7. PubMed ID: 18612108
    [No Abstract] [Full Text] [Related]

  • 24. The report of the Institute of Medicine on drug safety.
    Somberg J.
    Am J Ther; 2007 Jul 09; 14(1):1-2. PubMed ID: 17303967
    [No Abstract] [Full Text] [Related]

  • 25. Post-marketing surveillance of prescription drug safety: past, present, and future.
    Chen BK, Yang YT.
    J Leg Med; 2013 Jul 09; 34(2):193-213. PubMed ID: 23980746
    [No Abstract] [Full Text] [Related]

  • 26. FDA Adds Online REMS Table.
    Aschenbrenner DS.
    Am J Nurs; 2017 Nov 09; 117(11):21. PubMed ID: 29076851
    [No Abstract] [Full Text] [Related]

  • 27. The marketing of a drug.
    Wolfe SM.
    Health Med; 1982 Nov 09; 1(2):31-2. PubMed ID: 10257087
    [No Abstract] [Full Text] [Related]

  • 28. Congress responds to the IOM drug safety report--in full.
    Psaty BM, Korn D.
    JAMA; 2007 Nov 14; 298(18):2185-7. PubMed ID: 18000202
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The FDA Sentinel Initiative - An Evolving National Resource.
    Platt R, Brown JS, Robb M, McClellan M, Ball R, Nguyen MD, Sherman RE.
    N Engl J Med; 2018 Nov 29; 379(22):2091-2093. PubMed ID: 30485777
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. US lawmakers tackle safety reforms at the FDA.
    Zwillich T.
    Lancet; 2007 Jun 16; 369(9578):1989-90. PubMed ID: 17577942
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Report every adverse drug reaction! We're all in this together.
    Griffin GC, Parkinson RW, Woolley BH.
    Postgrad Med; 1997 Apr 16; 101(4):13-6. PubMed ID: 9126202
    [No Abstract] [Full Text] [Related]

  • 36. Drug-safety pilot makes the grade.
    Ledford H.
    Nature; 2014 Sep 25; 513(7519):472. PubMed ID: 25254456
    [No Abstract] [Full Text] [Related]

  • 37. Pilot projects to stimulate adverse drug reaction reporting.
    Fincham JE.
    J Clin Pharm Ther; 1987 Aug 25; 12(4):243-7. PubMed ID: 3624325
    [Abstract] [Full Text] [Related]

  • 38. US consumer group criticizes proposal to allow drug makers to challenge safety information.
    McCarthy M.
    BMJ; 2015 Mar 17; 350():h1514. PubMed ID: 25784706
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.